期刊文献+

肠道菌群及其代谢产物与T2DM发病机制及干预措施 被引量:8

Intestinal Microflora and Its Metabolites in Relation to the Pathogenesis and Intervention of T2DM
原文传递
导出
摘要 2型糖尿病(type 2 diabetes mellitus,T2DM)是一种因胰岛素分泌不足或胰岛素抵抗而引起的慢性代谢疾病,T2DM患病人数的快速增长使治疗和预防T2DM成为世界上亟待解决的医学问题。随着微生物组学技术的进步,肠道菌群及其代谢产物与T2DM的研究亦逐渐深入,肠道菌群可能成为治疗和预防T2DM的靶点。肠道菌群及其代谢产物作用于T2DM的潜在机制,主要是参与体内炎症反应、增加肠道短链脂肪酸产量、调节肠道胆汁酸的代谢、调节支链氨基酸的代谢等。目前,治疗T2DM的药物可能会产生一些副作用,而基于肠道菌群干预T2DM的措施相对安全无害。例如,可通过严格控制的特定结构饮食长期摄入或增加益生菌的长期摄取控制血糖,或通过口服可影响肠道菌群生态结构的降糖药物(二甲双胍、阿卡波糖)有效地调控血糖水平。综述基于肠道菌群及其代谢产物诱发T2DM的潜在机制,研讨基于肠道菌群干预T2DM的措施,从肠道菌群的新视角探索治疗T2DM的新方法,为彻底治疗T2DM提供一种新可能。 Type 2 diabetes mellitus(T2 DM)is a chronic metabolic disease caused by insufficient insulin secretion or insulin resistance.The rapid increase in the number of patients with T2 DM makes the treatment and prevention of T2 DM an urgent problem in the world.With the advancement of microbiome technology,the research on the intestinal flora,its metabolites and the T2 DM has gradually deepened.Perhaps the intestinal flora can be used as a target for the treatment and prevention of T2 DM.The potential mechanism of intestinal flora acting on T2 DM is reviewed.It mainly participates in the inflammatory response in the body,increasing the production of intestinal short-chain fatty acids,regulating the metabolism of intestinal bile acids and their product distribution,and ajusting the metabolism of branched-chain amino acids.Currently,drugs for T2 DM may have some side effects.Measures based on the intestinal flora to intervene in T2 DM are relatively safe and harmless.Long-term intake of a strictly controlled diet with a specific structure can be used to control blood sugar or increase the long-term intake of probiotics.It can also affect the ecological structure of the intestinal flora through oral administration.Sugar drugs(metformin and acarbose)effectively regulate blood sugar levels.The potential mechanism of T2 DM induced by the intestinal flora and its metabolites is reviewed,and measures for the intervention of T2 DM based on the intestinal flora are also discussed.In addition,new methods for the treatment of T2 DM from a new perspective of the intestinal flora are explored,which may provide a thorough treatment of T2 DM in the future.
作者 甘巧 孟庆雄 GAN Qiao;MENG Qing-xiong(Faculty of Life Science and Technology,Kunming University of Science and Technology,Kunming 650504,China)
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2022年第3期62-71,共10页 China Biotechnology
基金 国家自然科学基金(31860096)资助项目。
关键词 肠道菌群 2型糖尿病 代谢产物 二甲双胍 Intestinal microflora Type 2 diabetes mellitus(T2DM) Metabolite Metformin
  • 相关文献

参考文献3

二级参考文献9

共引文献5424

同被引文献117

引证文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部